J01 Effects of IONIS-HTTRX (RG6042) in patients with early huntington’s disease, results of the first htt-lowering drug trial
Sarah J Tabrizi, Blair Leavitt, Bernhard Landwehrmeyer, Edward Wild, Carsten Saft, Roger Barker, David Craufurd, Hugh Rickards, Anne Rosser, Josef Priller, Holly Kordasiewicz, Christian Czech, Eric Swayze, Daniel A Norris, Tiffany Baumann, Irene Gerlach, Scott Schobel, Anne Smith, Roger Lane, C Frank Bennett, on behalf of the HTT Rx CS1 study teams
Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A97-A98; DOI: 10.1136/jnnp-2018-EHDN.261
